Clinical Assessment

2

Review clinical trials related to Clinical Assessment. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Evaluation of Additive and Subtractive Onlay Restorations

The goal of this clinical trial is to learn whether onlay restorations produced by additive manufacturing \[three-dimensional (3D) printing\] and subtractive manufacturing \[Computer-Aided Design/Computer-Aided Manufacturing (CAD/CAM) milling\] perform equally well in vital posterior teeth. The main questions it aims to answer are: * Do 3D printed onlay restorations show similar marginal adaptation and clinical performance compared to CAD/CAM milled onlays? * Are there any differences in biological compatibility, surface properties, or postoperative sensitivity between the two techniques over time? Researchers will compare onlay restorations fabricated with 3D printing and CAD/CAM milling using a split-mouth study design. Participants will: * Receive one onlay restoration produced by 3D printing and another produced by CAD/CAM milling, placed on opposite sides of the mouth * Have checkups at baseline (1st week), 6 months, 12 months, and 18 months after treatment * Be evaluated using the Fédération Dentaire Internationale (FDI) criteria for marginal adaptation, surface quality, anatomical form, and biological compatibility

Participants needed: 29
Trial details
Age: 18-84Biological sex: AllType: InterventionalSponsor: Ayse Tugba Erturk AvundukUpdated: Sep 26, 2025Locations: 1
Eligibility criteria

Adults aged 18-84 years [+15]

Teeth with pulp necrosis or a history of endodontic treatment (previous root can... [+11]

Status: Recruiting

Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients

This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system. Data captured on the PatenSee system will be analyzed and evaluated against standard of care clinical monitoring of AV accesses.

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: PatenSee Ltd.Updated: Sep 26, 2025Locations: 2
Eligibility criteria

Male and female adult patient aged ≥18 years old [+4]

An active AV access infection [+6]